Docetaxel

देश: न्यूज़ीलैंड

भाषा: अंग्रेज़ी

स्रोत: Medsafe (Medicines Safety Authority)

सक्रिय संघटक:

Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg

थमां उपलब्ध:

REX Medical Ltd

INN (इंटरनेशनल नाम):

Docetaxel trihydrate 25.177 mg (equivalent to anhydrous docetaxel 20mg)

डोज़:

20 mg/mL

फार्मास्यूटिकल फॉर्म:

Concentrate for infusion

रचना:

Active: Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

पैकेज में यूनिट:

Vial, glass, Diluent, 1.5 mL

वर्ग:

Prescription

प्रिस्क्रिप्शन प्रकार:

Prescription

द्वारा बनाया गया:

Cipla Ltd

चिकित्सीय संकेत:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

उत्पाद समीक्षा:

Package - Contents - Shelf Life: Vial, glass, Diluent - 1.5 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 20 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

प्राधिकरण की तारीख:

2006-06-23